Page 25 - Elsevier News Today

Value opportunities await investors after years of negative sentiment

Your search history isn't looking too good.

ExactCure, a private French HealthTech company developing an innovative artificial intelligence device to tailor drug administration to each individual's profile A technology with CE...

<p>The updated <a href="https://ccs.ca/">Canadian Cardiovascular Society</a> (CCS)/<a href="https://caic-acci.org/">Canadian Association of Interventional Cardiology</a> (CAIC) antiplatelet therapy guidelines for primary and secondary prevention of atherosclerotic cardiovascular disease (ASCVD) provide recommendations based on the latest randomized evidence available in the literature. Updated by a panel of national experts, these <a href=&quo...

Near year's Amsterdam's Elsevier has released two reports looking at research and its impact beyond campuses and research hubs.

<p>Interstitial fluid plays a vital role in drug delivery and tumour treatment. However, few non-invasive measurement methods are available for measuring low-velocity biological fluid flow. Therefore, we developed a novel technology called interstitial flow velocity-MRI. Interstitial flow velocity-MRI has the potential to determine interstitial fluid flow velocity non-invasively and exhibits an intuitive velocity map.</p>

Agenda Revealed for the Premier Data Governance and Master Data Management Conference Europe, 11 – 14 March 2024, in London IRM UK, LONDON – 12/12/2023...

<p>Diet quality among adolescents in the United States is among the worst across all age groups, putting young people at risk for heart attack, stroke, and diabetes, among other cardiometabolic diseases later in life. The <a href="https://doi.org/10.1016/j.jneb.2023.10.003">research brief</a> shared in the <a href="https://www.jneb.org/"><em>Journal of Nutrition Education and Behavior</em></a>, published by Elsevier, used the <em&g...

Advancements in the care of premature babies are leading to improved survival rates. However, the incidence of neonatal diseases with life-long consequences such as bronchopulmonary dysplasia (BPD) and retinopathy of prematurity (ROP) is increasing.

The state of global health data is akin to a messy desk, and siloed data means providers are losing out on capabilities made possible by harnessing our own information.